Novozymes reveals the key to its supply chain management strategy
Novozymes has achieved a successful supply chain and risk mitigation strategy through implementing its own policy with chemicals company SAFC, says Luke Dimasi.
The marketing manager for Novozymes told Outsourcing-pharma that the firm has worked with both its customers and SAFC to develop a strategy which ensures balanced inventory surplus, as well as planning for future supplies.
And by crossing the new capabilities afforded by the partnership with its own risk mitigation policies – such as redundancy planning, and second site management – Dimasi said the Denmark-based firm has achieved a workable supply chain model.
Dimasi told Outsourcing-Pharma about the strategy during SAFC’s conference in Glasgow, where he presented the businesses approach.
